Hypermelanosis due to endocrine disorder (Q89733): Difference between revisions

← Older edit

@@ Property / CURIE @@
+CID11:ID_1908185920
@@ Property / CURIE: CID11:ID_1908185920 / rank @@
+Normal rank
@@ Property / Canary Token @@
+dki-india-ID_1908185920
@@ Property / Canary Token: dki-india-ID_1908185920 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 13 August 2026 / rank @@
+Normal rank

Latest revision as of 16:33, 15 August 2026

Diffuse hypermelanosis due to secretion of abnormal amounts of melanocyte stimulating hormones including beta MSH and ACTH. This may be seen with pituitary tumours (e.g. pituitary Cushing syndrome) or following adrenal failure (Addison disease) or adrenalectomy (Nelson syndrome). More rarely it may be seen with acromegaly and with hyperthyroidism.

Language	Label	Description	Also known as
default for all languages	ID_1908185920
English	Hypermelanosis due to endocrine disorder	Diffuse hypermelanosis due to secretion of abnormal amounts of melanocyte stimulating hormones including beta MSH and ACTH. This may be seen with pituitary tumours (e.g. pituitary Cushing syndrome) or following adrenal failure (Addison disease) or adrenalectomy (Nelson syndrome). More rarely it may be seen with acromegaly and with hyperthyroidism.